{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T08:13:23Z","timestamp":1793780003090,"version":"4.6.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100011307","name":"Association for Molecular Pathology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011307","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jmdjournal.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jmoldx.2022.11.002","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T05:29:50Z","timestamp":1670563790000},"page":"69-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Assessments of Somatic Variant Classification Using the Association for Molecular Pathology\/American Society of Clinical Oncology\/College of American Pathologists Guidelines"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4253-2369","authenticated-orcid":false,"given":"Marilyn M.","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine E.","family":"Cottrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrudula","family":"Pullambhatla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somak","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn L.","family":"Temple-Smolkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5545-9738","authenticated-orcid":false,"given":"Scott A.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy L.","family":"Vnencak-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2022.11.002_bib1","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1200\/JCO.2013.52.4298","article-title":"Physicians\u2019 attitudes about multiplex tumor genomic testing","volume":"32","author":"Gray","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib2","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1002\/cncr.30581","article-title":"Integrating next-generation sequencing into pediatric oncology practice: an assessment of physician confidence and understanding of clinical genomics","volume":"123","author":"Johnson","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib3","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nm.3559","article-title":"Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine","volume":"20","author":"Van Allen","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib4","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1093\/annonc\/mdu478","article-title":"Prioritizing targets for precision cancer medicine","volume":"25","author":"Andre","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib5","doi-asserted-by":"crossref","first-page":"djv098","DOI":"10.1093\/jnci\/djv098","article-title":"A decision support framework for genomically informed investigational cancer therapy","volume":"107","author":"Meric-Bernstam","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib6","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/gim.2015.47","article-title":"A classification system for clinical relevance of somatic variants identified in molecular profiling of cancer","volume":"18","author":"Sukhai","year":"2016","journal-title":"Genet Med"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","article-title":"Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists","volume":"19","author":"Li","year":"2017","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jmoldx.2017.11.002","article-title":"Authors\u2019 reply","volume":"20","author":"Li","year":"2018","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib10","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/s41436-020-0783-8","article-title":"Points to consider for reporting of germline variation in patients undergoing tumor testing: a statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"22","author":"Li","year":"2020","journal-title":"Genet Med"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib11","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/humu.23651","article-title":"Adapting crowdsourced clinical cancer curation in CIViC to the ClinGen minimum variant level data community-driven standards","volume":"39","author":"Danos","year":"2018","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib12","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ng.3774","article-title":"CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer","volume":"49","author":"Griffith","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib13","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.7150\/jca.29535","article-title":"Challenges of providing concordant interpretation of somatic variants in non\u2013small cell lung cancer: a multicenter study","volume":"10","author":"Gao","year":"2019","journal-title":"J Cancer"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib14","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jmoldx.2019.10.010","volume":"22","author":"Sirohi","year":"2020","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3747\/co.26.5281","article-title":"The somatic curation and interpretation across laboratories (SOCIAL) project\u2014 current state of solid-tumour variant interpretation for molecular pathology in Canada","volume":"26","author":"Spence","year":"2019","journal-title":"Curr Oncol"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cancergen.2019.11.008","article-title":"Molecular profiling of gynecologic cancers for treatment and management of disease \u2013 demonstrating clinical significance using the AMP\/ASCO\/CAP guidelines for interpretation and reporting of somatic variants","volume":"242","author":"Nie","year":"2020","journal-title":"Cancer Genet"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib17","doi-asserted-by":"crossref","first-page":"e00170","DOI":"10.1016\/j.plabm.2020.e00170","article-title":"Identification of challenges and a framework for implementation of the AMP\/ASCO\/CAP classification guidelines for reporting somatic variants","volume":"21","author":"Parikh","year":"2020","journal-title":"Pract Lab Med"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib18","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.3390\/cancers11122030","article-title":"Standardization of somatic variant classifications in solid and haematological tumours by a two-level approach of biological and clinical classes: an initiative of the Belgian compermed expert panel","volume":"11","author":"Froyen","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.21873\/cgp.20250","article-title":"Comparison of open-access databases for clinical variant interpretation in cancer: a case study of MDS\/AML","volume":"18","author":"Banck","year":"2021","journal-title":"Cancer Genomics Proteomics"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib20","doi-asserted-by":"crossref","first-page":"822","DOI":"10.5858\/arpa.2021-0179-CP","article-title":"Tiered somatic variant classification adoption has increased worldwide with some practice differences based on location and institutional setting","volume":"146","author":"Bruehl","year":"2022","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib21","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/annonc\/mdy263","article-title":"A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of Molecular Targets (ESCAT)","volume":"29","author":"Mateo","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib22","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1146\/annurev.biochem.77.060806.091238","article-title":"Structural biology of the tumor suppressor p53","volume":"77","author":"Joerger","year":"2008","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.lungcan.2017.06.014","article-title":"Prognostic and predictive effects of TP53 co-mutation in patients with EGFR-mutated non-small cell lung cancer (NSCLC)","volume":"111","author":"Labb\u00e9","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib25","doi-asserted-by":"crossref","first-page":"e77305","DOI":"10.1371\/journal.pone.0077305","article-title":"PTCH1 gene mutations in keratocystic odontogenic tumors: a study of 43 Chinese patients and a systematic review","volume":"8","author":"Guo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib26","series-title":"WHO Classification of Tumours of the Central Nervous System","author":"Louis","year":"2016"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib27","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S1470-2045(18)30242-0","article-title":"Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort","volume":"19","author":"Waszak","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib28","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ccr.2014.02.004","article-title":"Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition","volume":"25","author":"Kool","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib29","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1126\/science.1229259","article-title":"Highly recurrent TERT promoter mutations in human melanoma","volume":"339","author":"Huang","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib30","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1230062","article-title":"TERT promoter mutations in familial and sporadic melanoma","volume":"339","author":"Horn","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib31","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00401-013-1198-2","article-title":"TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma","volume":"126","author":"Remke","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib32","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00401-012-0958-8","article-title":"Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, group 3, and group 4 medulloblastomas","volume":"123","author":"Kool","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jmoldx.2016.11.001","article-title":"Molecular biomarkers for the evaluation of colorectal cancer","volume":"19","author":"Sepulveda","year":"2017","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib34","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJMoa1305275","article-title":"Panitumumab\u2013FOLFOX4 treatment and RAS mutations in colorectal cancer","volume":"369","author":"Douillard","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib35","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1200\/JCO.2015.63.9674","article-title":"Extended RAS gene mutation testing in metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy: American Society of Clinical Oncology provisional clinical opinion update 2015","volume":"34","author":"Allegra","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib36","article-title":"Prognostic significance of U2AF1 mutations in myelodysplastic syndromes: a meta-analysis","volume":"48","author":"Li","year":"2020","journal-title":"J Int Med Res"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib37","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1200\/JCO.2016.71.9807","article-title":"Molecular biomarkers for the evaluation of colorectal cancer: guideline from the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology","volume":"35","author":"Sepulveda","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib38","series-title":"WHO Classification of Tumours: Central Nervous System Tumours","year":"2021"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib39","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1038\/leu.2016.212","article-title":"Somatic PHF6 mutations in 1760 cases with various myeloid neoplasms","volume":"30","author":"Mori","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib40","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/leu.2010.247","article-title":"PHF6 mutations in adult acute myeloid leukemia","volume":"25","author":"Van Vlierberghe","year":"2011","journal-title":"Leukemia"},{"issue":"Suppl 1","key":"10.1016\/j.jmoldx.2022.11.002_bib41","article-title":"The impact of PHF6 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia","volume":"134","author":"Chien","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib42","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","year":"2017"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib43","doi-asserted-by":"crossref","first-page":"D805","DOI":"10.1093\/nar\/gku1075","article-title":"COSMIC: exploring the world\u2019s knowledge of somatic mutations in human cancer","volume":"43","author":"Forbes","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib44","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib45","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib46","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":"The cancer genome atlas pan-cancer analysis project","volume":"45","author":"Weinstein","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib47","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1158\/2159-8290.CD-17-0151","article-title":"AACR project genie: powering precision medicine through an international consortium","volume":"7","author":"Sweeney","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib48","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/humu.23035","article-title":"TP53 variations in human cancers: new lessons from the IARC TP53 database and genomics data","volume":"37","author":"Bouaoun","year":"2016","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jmoldx.2022.11.002_bib49","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1200\/JOP.19.00201","article-title":"When should tumor genomic profiling prompt consideration of germline testing?","volume":"15","author":"DeLeonardis","year":"2019","journal-title":"J Oncol Pract"}],"updated-by":[{"DOI":"10.1016\/j.jmoldx.2023.01.007","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000}}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157822003397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157822003397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T21:19:18Z","timestamp":1706822358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157822003397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S1525157822003397"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2022.11.002","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jmoldx.2023.01.007","asserted-by":"object"}]},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessments of Somatic Variant Classification Using the Association for Molecular Pathology\/American Society of Clinical Oncology\/College of American Pathologists Guidelines","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2022.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}